FDA rallies HRT manufacturers amid US-wide estradiol patch shortage

The uptick in demand for HRT comes shortly after the FDA removed the long-standing black box label warning from such products. The uptick in demand for HRT comes shortly after the FDA removed their long-standing associated black box label warning. An uptick in HRT use across the US follows the FDA’s removal of the long-standing black box label warning associated with these therapies. Credit: Andrey_Popov / Shutterstock.com. The US Food and Drug Administration (FDA) has started working with six drug-device manufacturers involved in the production of transdermal estradiol patches to bolster supplies to the American public amid an ongoing shortage.…

Source: Medical Device Network